Crescent Capital BDC, Inc. (NASDAQ:CCAP) Declares Quarterly Dividend of $0.07

Crescent Capital BDC, Inc. (NASDAQ:CCAPGet Free Report) declared a quarterly dividend on Tuesday, November 12th,Zacks Dividends reports. Stockholders of record on Friday, November 29th will be paid a dividend of 0.07 per share on Monday, December 16th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend is Friday, November 29th.

Crescent Capital BDC has a dividend payout ratio of 82.8% meaning its dividend is currently covered by earnings, but may not be in the future if the company’s earnings tumble. Analysts expect Crescent Capital BDC to earn $1.99 per share next year, which means the company should continue to be able to cover its $1.68 annual dividend with an expected future payout ratio of 84.4%.

Crescent Capital BDC Price Performance

CCAP stock traded down $0.03 on Wednesday, reaching $18.78. 139,236 shares of the company’s stock were exchanged, compared to its average volume of 132,574. The stock has a fifty day moving average of $18.39 and a 200-day moving average of $18.40. The firm has a market cap of $695.99 million, a PE ratio of 7.37 and a beta of 0.81. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17. Crescent Capital BDC has a twelve month low of $15.91 and a twelve month high of $19.63.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last announced its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.58 by $0.01. Crescent Capital BDC had a net margin of 47.06% and a return on equity of 12.20%. The business had revenue of $48.95 million during the quarter, compared to the consensus estimate of $48.05 million. During the same quarter last year, the firm posted $0.56 EPS. As a group, equities analysts predict that Crescent Capital BDC will post 2.35 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on CCAP. LADENBURG THALM/SH SH started coverage on Crescent Capital BDC in a research note on Monday, September 30th. They set a “buy” rating and a $20.00 price target on the stock. Wells Fargo & Company lowered their target price on Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 14th. Finally, Bank of America cut their price target on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 15th. One research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $19.00.

View Our Latest Stock Analysis on CCAP

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Dividend History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.